Clinical Trial Update: SCI-110 in the Treatment of Tourette Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of SCI-110 for Tourette Syndrome is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Drugs mentioned

• SCI-110

Snippet

Sponsor: Neurothera Labs Inc. | Conditions: Tourette Syndrome | Phase 2 | Status: NOT_YET_RECRUITING